DBS Group Research’s Woon Bing Yong and Ling Lee Keng have downgraded their rating for Medtecs International from ‘buy’ to ‘hold’, as well as lowering their target price to 92 cents from $1.25. 

They cited a “disappointing” performance for 1QFY2021, noting the decline in revenue to US$42.2 million ($55.87 million). 

For more stories about where the money flows, click here for our Capital section

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook